State of Wisconsin Investment Board’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.19M | Sell |
63,458
-14,112
| -18% | -$264K | ﹤0.01% | 1506 |
|
2025
Q1 | $1.4M | Buy |
77,570
+5,119
| +7% | +$92.1K | ﹤0.01% | 1373 |
|
2024
Q4 | $1.22M | Buy |
72,451
+43,591
| +151% | +$733K | ﹤0.01% | 1446 |
|
2024
Q3 | $467K | Buy |
+28,860
| New | +$467K | ﹤0.01% | 1895 |
|
2022
Q4 | – | Sell |
-17,381
| Closed | -$205K | – | 2625 |
|
2022
Q3 | $205K | Sell |
17,381
-985
| -5% | -$11.6K | ﹤0.01% | 2399 |
|
2022
Q2 | $208K | Sell |
18,366
-4,504
| -20% | -$51K | ﹤0.01% | 2470 |
|
2022
Q1 | $684K | Sell |
22,870
-2,450
| -10% | -$73.3K | ﹤0.01% | 1723 |
|
2021
Q4 | $671K | Sell |
25,320
-5,540
| -18% | -$147K | ﹤0.01% | 1576 |
|
2021
Q3 | $1.12M | Hold |
30,860
| – | – | ﹤0.01% | 1419 |
|
2021
Q2 | $1.34M | Buy |
30,860
+7,990
| +35% | +$347K | ﹤0.01% | 1368 |
|
2021
Q1 | $782K | Sell |
22,870
-230
| -1% | -$7.86K | ﹤0.01% | 1435 |
|
2020
Q4 | $808K | Sell |
23,100
-2,870
| -11% | -$100K | ﹤0.01% | 1374 |
|
2020
Q3 | $623K | Hold |
25,970
| – | – | ﹤0.01% | 1394 |
|
2020
Q2 | $475K | Hold |
25,970
| – | – | ﹤0.01% | 1443 |
|
2020
Q1 | $405K | Buy |
25,970
+740
| +3% | +$11.5K | ﹤0.01% | 1398 |
|
2019
Q4 | $540K | Hold |
25,230
| – | – | ﹤0.01% | 1410 |
|
2019
Q3 | $472K | Buy |
25,230
+2,240
| +10% | +$41.9K | ﹤0.01% | 1347 |
|
2019
Q2 | $600K | Buy |
22,990
+510
| +2% | +$13.3K | ﹤0.01% | 1272 |
|
2019
Q1 | $578K | Buy |
22,480
+5,150
| +30% | +$132K | ﹤0.01% | 1312 |
|
2018
Q4 | $399K | Buy |
17,330
+130
| +0.8% | +$2.99K | ﹤0.01% | 1371 |
|
2018
Q3 | $552K | Buy |
17,200
+8,700
| +102% | +$279K | ﹤0.01% | 1381 |
|
2018
Q2 | $241K | Hold |
8,500
| – | – | ﹤0.01% | 1414 |
|
2018
Q1 | $301K | Hold |
8,500
| – | – | ﹤0.01% | 1362 |
|
2017
Q4 | $330K | Hold |
8,500
| – | – | ﹤0.01% | 1351 |
|
2017
Q3 | $216K | Hold |
8,500
| – | – | ﹤0.01% | 1394 |
|
2017
Q2 | $232K | Buy |
+8,500
| New | +$232K | ﹤0.01% | 1391 |
|